c反应蛋白/白蛋白比值在st段抬高型心肌梗死中的预后价值。

Q2 Medicine

Interventional Medicine and Applied Science Pub Date : 2019-10-07 eCollection Date: 2020-09-01 DOI:10.1556/1646.11.2019.20

Lutfu Askin, Okan Tanriverdi, Hakan Tibilli, Serdar Turkmen

{"title":"c反应蛋白/白蛋白比值在st段抬高型心肌梗死中的预后价值。","authors":"Lutfu Askin, Okan Tanriverdi, Hakan Tibilli, Serdar Turkmen","doi":"10.1556/1646.11.2019.20","DOIUrl":null,"url":null,"abstract":"Serum C-reactive protein (CRP)/albumin ratio (CAR) is demonstrated as a more precise marker in determining the prognosis of critical diseases than albumin and CRP levels, separately. Recently, inflammatory biomarkers are increasingly used for both screening and prognosis of coronary artery disease (CAD). As an ischemia-dependent risk index, CAR is an independent marker of in-hospital and long-term all-cause mortality in ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention. The results indicate that CAR is a more effective prognostic marker than either CRP or albumin.","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":"11 3","pages":"168-171"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467334/pdf/imas-11-168.pdf","citationCount":"5","resultStr":"{\"title\":\"Prognostic value of C-reactive protein/albumin ratio in ST-segment elevation myocardial infarction.\",\"authors\":\"Lutfu Askin, Okan Tanriverdi, Hakan Tibilli, Serdar Turkmen\",\"doi\":\"10.1556/1646.11.2019.20\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Serum C-reactive protein (CRP)/albumin ratio (CAR) is demonstrated as a more precise marker in determining the prognosis of critical diseases than albumin and CRP levels, separately. Recently, inflammatory biomarkers are increasingly used for both screening and prognosis of coronary artery disease (CAD). As an ischemia-dependent risk index, CAR is an independent marker of in-hospital and long-term all-cause mortality in ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention. The results indicate that CAR is a more effective prognostic marker than either CRP or albumin.\",\"PeriodicalId\":45181,\"journal\":{\"name\":\"Interventional Medicine and Applied Science\",\"volume\":\"11 3\",\"pages\":\"168-171\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467334/pdf/imas-11-168.pdf\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Interventional Medicine and Applied Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1556/1646.11.2019.20\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/9/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventional Medicine and Applied Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1556/1646.11.2019.20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/9/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 5

摘要

血清c -反应蛋白(CRP)/白蛋白比率(CAR)被证明是确定危重疾病预后的更精确的标志物，而不是白蛋白和CRP水平。近年来，炎症生物标志物越来越多地用于冠状动脉疾病(CAD)的筛查和预后。CAR是一种缺血依赖的危险指标，是st段抬高型心肌梗死(STEMI)经皮冠状动脉介入治疗后住院和长期全因死亡率的独立指标。结果表明，CAR是比CRP或白蛋白更有效的预后标志物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Prognostic value of C-reactive protein/albumin ratio in ST-segment elevation myocardial infarction.

Serum C-reactive protein (CRP)/albumin ratio (CAR) is demonstrated as a more precise marker in determining the prognosis of critical diseases than albumin and CRP levels, separately. Recently, inflammatory biomarkers are increasingly used for both screening and prognosis of coronary artery disease (CAD). As an ischemia-dependent risk index, CAR is an independent marker of in-hospital and long-term all-cause mortality in ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention. The results indicate that CAR is a more effective prognostic marker than either CRP or albumin.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Interventional Medicine and Applied Science MEDICINE, GENERAL & INTERNAL-

CiteScore

1.60

自引率

0.00%

发文量

审稿时长

15 weeks